KCNQ1 and type 2 diabetes mellitus: Another study indicated that patients with T2DM with the KCNQ1 rs2237892 T allele were more likely to have a positive response to repaglinide in terms of postprandial plasma glucose (PPG) levels rather than HOMA-IR levels14.